181 related articles for article (PubMed ID: 7233337)
1. Embryotoxicity in mice of phosphonacetyl-L-aspartic acid (PALA), a new antitumor agent. II. Studies on its mechanism and reversibility.
Sieber SM; Botkin CC; Leslie KA; Cooney DA
Teratology; 1980 Dec; 22(3):321-8. PubMed ID: 7233337
[TBL] [Abstract][Full Text] [Related]
2. Embryotoxicity in mice of phosphonacetyl-L-aspartic acid (PALA), a new antitumor agent. I. Embryolethal, teratogenic, and cytogenetic effects.
Sieber SM; Botkin CC; Soong P; Lee EC; Whang-Peng J
Teratology; 1980 Dec; 22(3):311-9. PubMed ID: 7233336
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the teratogenic activity of hycanthone in mice and rabbits.
Sieber SM; Adamson RH
J Toxicol Environ Health; 1975 Nov; 1(2):309-22. PubMed ID: 1206773
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
[TBL] [Abstract][Full Text] [Related]
5. An enzymatic technique for measuring N-phosphonacetyl-L-aspartic acid in tissues.
Cooney DA; Karlowicz MG; Cubillan J; Roettger M; Jayaram HN
Cancer Treat Rep; 1978 Oct; 62(10):1503-7. PubMed ID: 361225
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA).
Jayaram HN; Cooney DA; Vistica DT; Kariya S; Johnson RK
Cancer Treat Rep; 1979 Aug; 63(8):1291-302. PubMed ID: 476706
[TBL] [Abstract][Full Text] [Related]
7. Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice.
Sieber SM; Whang-Peng J; Botkin C; Knutsen T
Teratology; 1978 Aug; 18(1):31-47. PubMed ID: 694777
[TBL] [Abstract][Full Text] [Related]
8. Embryotoxicity of benzo(a)pyrene and some of its synthetic derivatives in Swiss mice.
Barbieri O; Ognio E; Rossi O; Astigiano S; Rossi L
Cancer Res; 1986 Jan; 46(1):94-8. PubMed ID: 3753553
[TBL] [Abstract][Full Text] [Related]
9. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
10. Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
Ognio E; Lapide M; Ottone M; Mandys V; Peterka M; Parodi B; Viale M
Arch Toxicol; 2003 Oct; 77(10):584-90. PubMed ID: 14574446
[TBL] [Abstract][Full Text] [Related]
11. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
[TBL] [Abstract][Full Text] [Related]
12. Embryotoxicity of cisplatin in rats and mice.
Keller KA; Aggarwal SK
Toxicol Appl Pharmacol; 1983 Jun; 69(2):245-56. PubMed ID: 6683433
[TBL] [Abstract][Full Text] [Related]
13. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
14. Transplacental passage of label after administration of (3H) retinoic acid (vitamin A acid) to pregnant mice.
Kochhar DM
Teratology; 1976 Aug; 14(1):53-63. PubMed ID: 960011
[TBL] [Abstract][Full Text] [Related]
15. Embryotoxic effects of CKD-602, a new camptothecin anticancer agent, in rats.
Chung MK; Kim JC; Han SS
Reprod Toxicol; 2005; 20(1):165-73. PubMed ID: 15808800
[TBL] [Abstract][Full Text] [Related]
16. Effect of day of exposure on the developmental toxicity of manganese in mice.
Colomina MT; Domingo JL; Llobet JM; Corbella J
Vet Hum Toxicol; 1996 Feb; 38(1):7-9. PubMed ID: 8825740
[TBL] [Abstract][Full Text] [Related]
17. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
Willhite CC; Lovey A; Eckhoff C
Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
[TBL] [Abstract][Full Text] [Related]
18. Developmental toxicity study with triethylene glycol given by gavage to CD rats and CD-1 mice.
Ballantyne B; Snellings WM
J Appl Toxicol; 2005; 25(5):418-26. PubMed ID: 16092104
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea as a reference standard in teratological screening. Comparison of the embryotoxic and teratogenic effects following single intraperitoneal or repeated oral administrations to pregnant rats.
Aliverti V; Bonanomi L; Giavini E
Arch Toxicol Suppl; 1980; 4():239-47. PubMed ID: 6933910
[TBL] [Abstract][Full Text] [Related]
20. Placental transfer of vigabatrin (gamma-vinyl GABA) and its effect on concentration of amino acids in the embryo of TO mice.
Abdulrazzaq YM; Padmanabhan R; Bastaki SM; Ibrahim A; Bener A
Teratology; 2001 Mar; 63(3):127-33. PubMed ID: 11283969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
